Krill Oil
Natural health product licensed in Canada
- Licence holder
- Vitaminol Inc.
- NPN or DIN-HM
- 80126184
- Status
- Active licence
- Licence date
- 14 August 2023
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Eau purifiée, Gélatine, Glycérine, Sorbitol, Ethylvanilline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants et Adolescents | minimum: 9 years ; maximum: 17 years | minimum: 1 Capsule ; maximum: 2 Capsule | 1 Tous les jours |
| Adultes | minimum: 18 years | 4 Capsule | 1 Tous les jours |
| Femmes | minimum: 18 years | 4 Capsule | 1 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 8 years | 1 Capsule | 1 Tous les jours |
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
| Adultes | minimum: 18 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Source of omega-3 fatty acids for the maintenance of good health. Source of the omega-3 fatty acids such as EPA and DHA. Helps to relieve symptoms of dysmenorrhea and premenstrual syndrome. Helps to relieve symptoms of premenstrual syndrome. Helps to maintain cardiovascular health. Helps to reduce serum triglycerides/triacylglycerols in conjunction with conventional statin therapy. Helps to reduce the levels of LDL cholesterol in conjunction with conventional statin therapy. Helps to increase the levels of HDL cholesterol in conjunction with conventional statin therapy. Helps to reduce pain associated with osteoarthritis. Helps to reduce C reactive protein levels, a clinical marker of inflammation. Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80126184
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.